As described above, heterozygous inactivation of Cav1.2 in smooth muscle also produced a ketamine cystitis-like bladder phenotype, and intravesical infusion of Bay k8644 during CMG corrected the associated voiding abnormalities (Fig. 9d). The gene discussed is CACNA1C; the disease is cystitis.